Edition:
United States

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

10.19USD
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
$10.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,104
52-wk High
$17.89
52-wk Low
$3.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jul 6.22 0.038
FY 2018 Apr '18 4.92 -0.057
Jan '18 5.08 -0.007
Oct 5.20 -0.009
Jul 5.03 -0.061
FY 2017 Apr '17 3.72 -0.196
Jan '17 3.57 -0.128
Oct 4.46 -0.046
Jul 3.67 -0.259
FY 2016 Apr '16 2.84 -0.297
Jan '16 2.55 -0.277
Oct 2.97 -0.293
Jul 2.82 -0.335
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-18 2 5.01 5.20 4.83 --
Quarter Ending Jul-19 1 7.07 7.07 7.07 --
Year Ending Apr-18 2 20.32 20.50 20.15 --
Year Ending Apr-19 3 25.28 25.40 25.22 --
Year Ending Apr-20 2 30.82 31.00 30.63 --
Earnings (per share)
Quarter Ending Apr-18 2 -0.04 -0.03 -0.04 --
Quarter Ending Jul-19 1 0.03 0.03 0.03 --
Year Ending Apr-18 2 -0.07 -0.04 -0.10 --
Year Ending Apr-19 3 0.16 0.19 0.14 --
Year Ending Apr-20 2 0.22 0.25 0.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.63 33.59
P/E High - Last 5 Yrs. -- 301.04 45.05
P/E Low - Last 5 Yrs. -- 83.19 24.37
Beta -0.44 0.93 0.91
Price to Sales (TTM) 2.28 119.19 5.69
Price to Book (MRQ) 131.79 14.53 5.11
Price to Tangible Book (MRQ) -- 13.73 6.54
Price to Cash Flow (TTM) -- 65.35 23.52
% Owned Institutions 38.05 13.41 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.48
Dividend Yield - 5 Year Avg -- 0.33 1.50
Dividend 5 Year Growth Rate -- 2.84 5.09
Payout Ratio(TTM) -- 25.29 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 37.14 376.88 7.43
Sales (TTM) vs TTM 1 Yr. Ago 39.44 95.70 5.86
Sales - 5 Yr. Growth Rate 16.60 28.71 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago 76.29 28.13 21.17
EPS (TTM) vs TTM 1 Yr. Ago 61.61 -- --
EPS - 5 Yr. Growth Rate -- 32.53 10.63
Capital Spending - 5 Yr. Growth Rate 8.10 35.83 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.10 2.26
Current Ratio (MRQ) 0.57 5.34 3.09
LT Debt to Equity (MRQ) 0.00 35.90 11.53
Total Debt to Equity (MRQ) 0.00 37.76 15.71
Interest Coverage (TTM) -- -89.19 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 41.45 40.11 54.07
Gross Margin - 5 Yr. Avg. 36.84 48.16 51.83
EBITD Margin (TTM) -28.13 -- --
EBITD - 5 Yr. Avg -75.71 -543.09 11.80
Operating Margin (TTM) -29.22 -781.87 4.85
Operating Margin - 5 Yr. Avg. -77.43 -563.63 7.45
Pre-Tax Margin (TTM) -29.81 -745.99 5.82
Pre-Tax Margin - 5 Yr. Avg. -79.42 -568.88 7.86
Net Profit Margin (TTM) -29.87 -746.96 2.08
Net Profit Margin - 5 Yr. Avg. -79.90 -571.58 4.10
Effective Tax Rate (TTM) -- 25.08 23.39
Effective Tax Rate - 5 Yr. Avg. -- 20.19 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,493,787 905,637,302
Net Income/Employee (TTM) -- 826,583 107,327,405
Receivable Turnover (TTM) 7.81 19.51 5.95
Inventory Turnover (TTM) -- 2.77 3.63
Asset Turnover (TTM) 2.34 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -70.01 -2.01 11.52
Return on Assets - 5 Yr. Avg. -96.50 2.45 12.71
Return on Investment (TTM) -258.97 -0.64 15.05
Return on Investment - 5 Yr. Avg. -179.32 1.26 16.50
Return on Equity (TTM) -289.15 0.08 16.62
Return on Equity - 5 Yr. Avg. -212.42 1.77 17.61
  1 Year 3 Year 5 Year
Sales % 37.82 10.09 16.60
EPS (TTM) % 46.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Champions Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.54 7.69 71 58
13 Week 35.41 28.81 83 60
26 Week 17.57 8.63 67 79
52 Week 112.20 79.85 89 46
YTD 37.55 20.80 68 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.56%
# of Holders: 44
Total Shares Held: 5,868,457
3 Mo. Net Change: 1,072,010
# New Positions: 25
# Closed Positions: 5
# Increased Positions: 34
# Reduced Positions: 8
# Net Buyers: 26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.